Remission after Immunotherapy tagged posts

In 27 of 29 participants whose responses were evaluated a few weeks after the infusion, a high-sensitivity test could detect no trace of their cancer in their bone marrow. The CAR T cells eliminated cancers anywhere in the body they appeared. Credit: © kukhunthod / Fotolia

‘Extraordinary’ but short-term results from early-stage trial of engineered immune cells.27 of29 patients with an advanced type of leukemia that had proved resistant to multiple other forms of therapy went into remission after their T cells were genetically engineered with a synthetic receptor molecule called a CAR (for chimeric antigen receptor) that empowers the T cells to recognize and kill cancer cells with marker CD19.

This trial was designed to evaluate the safety of administering the engineered cells and to lay t...